NUVAXOVID Trademark

Trademark Overview

On Tuesday, July 6, 2021, a trademark application was filed for NUVAXOVID with the United States Patent and Trademark Office. The USPTO has given the NUVAXOVID trademark a serial number of 90813420. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, May 2, 2024. This trademark is owned by Novavax, Inc.. The NUVAXOVID trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for the treatment and prevention of Covid-19
nuvaxovid

General Information

Serial Number90813420
Word MarkNUVAXOVID
Filing DateTuesday, July 6, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, May 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements

Description of MarkThe mark consists of the word "NUVAXOVID" below a left and right-wing design joining at the center, made up of different shaped circles.
Goods and ServicesVaccines for the treatment and prevention of Covid-19

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovavax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Friday, July 9, 2021NEW APPLICATION ENTERED
Wednesday, September 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 16, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, February 1, 2022ASSIGNED TO EXAMINER
Wednesday, February 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 25, 2022SOU TEAS EXTENSION RECEIVED
Monday, July 25, 2022SOU EXTENSION 1 FILED
Monday, July 25, 2022SOU EXTENSION 1 GRANTED
Wednesday, July 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023SOU EXTENSION 2 FILED
Thursday, April 13, 2023SOU EXTENSION 2 GRANTED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 1, 2023SOU EXTENSION 3 FILED
Wednesday, November 1, 2023SOU EXTENSION 3 GRANTED
Friday, November 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 2, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024SOU EXTENSION 4 FILED
Thursday, May 2, 2024SOU EXTENSION 4 GRANTED
Friday, May 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

nuvaxovid covid prevention treatment vaccines